AGING Supplementary Figure 3 . The value of high LSP1 expression in the response prediction to radio-and chemotherapy in GBM.
(A and B) Kaplan-Meier curves described the association between LSP1 expression and the survival of GBM patients treated with or without radiotherapy (A, TCGA-4502A mRNA microarray; B, TCGA-U133 mRNA microarray; with log-rank test). (C-E) The comparison of LSP1 expression analyzed in GBM with or without MGMT promoter methylation patients (C, TCGA RNA sequencing dataset; D, TCGA 4502A microarray; E,TCGA U133 microarray; with t test). (F and G) Kaplan-Meier curves describing the correlation between LSP1 expression and the survival of GBM patients with different MGMT promoter status (F, TCGA 4502A microarray; G TCGA U133 microarray; with log-rank test). (H and I) Kaplan-Meier curves described the correlation between LSP1 expression and the survival of GBM patients receiving chemotherapy (H, TCGA 4502A microarray; I, TCGA U133 microarray; with log-rank test). ns, *, **, ***, and **** indicate no significance, P < 0.05, P < 0.01, P < 0.001, and P < 0.0001, respectively. GBM, glioblastoma multiforme; MGMT, O 6 -methylguanine-DNA methyltransferase.
www.aging-us.com 4 AGING Supplementary Figure 4. Functional enrichment analysis revealing the association of LSP1 with immunologic events. (A and B) Bubble chart described the biological processes associated with LSP1-negative-correlated genes by GO analysis in GBM (A, CGGA RNA sequencing dataset; B, TCGA RNA sequencing dataset). Bubble diameter: enrichment gene counts; abscissa: -log 10 P-value P < 0.05. (C and D) GSEA indicated a significantly enhanced immune response and inflammatory response in GBM patients with high LSP1 expression (C, CGGA RNA sequencing dataset; D, TCGA RNA sequencing dataset). P < 0.05 and FDR < 0.01. GBM, glioblastoma multiforme.
